Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Borkenholm AS | 45,905 | net | 10 Nov 2025 | tx 4+45,905 |
| OncoZenge AB | 29,270 | net | 05 Mar 2021 | tx 2+29,270 |
| Calliditas Therapeutics ab | 14,250 | net | 02 Sept 2024 | tx 5+71,535−57,285 |
| Danske Bank A/S | 3,000 | net | 21 Jul 2022 | tx 1+3,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Nov 2025 | PURCHASE | Borkenholm AS | 2,000 | 9.85 SEK | first after silence |
| 02 Sept 2024 | SALE | Calliditas Therapeutics ab | 57,285 | 208.00 SEK | |
| 12 Jul 2024 | GRANT_AWARD | Calliditas Therapeutics ab | 4,086 | 0.00 SEK | |
| 12 Aug 2022 | GRANT_AWARD | Calliditas Therapeutics ab | 8,449 | 0.00 SEK | |
| 21 Jul 2022 | PURCHASE | Danske Bank A/S | 3,000 | 21.43 SEK | first after silence |
| 05 Mar 2021 | PURCHASE | Borkenholm AS | 14,635 | 10.25 SEK | |
| 19 Feb 2021 | PURCHASE | Borkenholm AS | 14,635 | 0.00 SEK | deriv |
| 17 Jun 2020 | OTHER | Calliditas Therapeutics ab | 29,500 | 0.00 SEK | deriv |
| 17 Jun 2020 | OTHER | Calliditas Therapeutics ab | 29,500 | 42.36 SEK |
2 purchases reported after at least 12 months of silence — most recent on 10 Nov 2025.